Latest Commercial Production News

Papyrus Australia moved its banana-fibre technology into early commercialisation during FY26, signing an estimated $4.2 million TBS supply contract and delivering commercial-scale samples. But the company ended the year with $257,077 cash, negative equity and an auditor-flagged material uncertainty over its ability to continue as a going concern.

Tanami Gold has entered FY27 with funding in place for a 3,500-metre underground decline at Groundrush, after raising $70.5 million and reporting a 2.8 million ounce Central Tanami resource. The project remains in the study and resource-definition phase, with no Ore Reserve or production decision yet disclosed.

Gold Hydrogen has advanced Ramsay drilling, testing and commercial studies, but its annual report carries a material uncertainty over the company’s ability to continue as a going concern. The pre-revenue explorer ended FY2026 with $9.42 million in cash after spending heavily on exploration.

Zeotech Limited (ASX:ZEO) is moving Toondoon toward its first direct-shipping kaolin export after securing a potential A$200 million offtake agreement, while AusPozz™ and zeoteCH₄® produce encouraging trial results. The progress came alongside an A$8.15 million FY26 loss, negative operating cash flow and an acknowledgement that further funding may be required.

Agrimin has completed its withdrawal from the Mackay Potash Project and repositioned itself around exploration at the 480-square-kilometre Mount Squires Project. The pivot reduced the company’s annual loss, but left it with $1.08 million in cash, net current liabilities and no JORC mineral resources or ore reserves.

Antimony Resources has begun trading under the ANT code as its Tecomatlán processing plant in Mexico moves closer to its first processing campaign. About 200 tonnes of mineralised material has been prepared, but assay results and commissioning outcomes are still to come.

VHM's refreshed feasibility study projects an A$807 million pre-tax NPV for its Goschen rare earths and mineral sands project, with approvals and major procurement work substantially advanced. The project still needs financing, lender due diligence and a Final Investment Decision before construction can begin.

BluGlass has begun a three-to-five-month, A$286,000 feasibility collaboration with global photonics company Coherent to develop a novel gallium nitride device for scientific and medical applications. The agreement offers technical and commercial promise, but does not yet include a production commitment or confirmed product launch.

Ramelius Resources has lifted its FY30 production outlook to as much as 610,000 ounces while committing up to A$570 million of growth capital in FY27. The plan puts a larger Mt Magnet processing hub at the centre of the company’s expansion, but also raises the execution and cost stakes.

American Tungsten & Antimony has produced antimony ingot from Arizona-mined material at its Nevada refinery, providing the first physical demonstration of its proposed US mine-to-metal chain. The milestone creates samples for testing and customer qualification, but the underlying asset acquisition remains incomplete and product quality is yet to be disclosed.

Everest Metals moved Mt Dimer into mining, established a 260,780-ounce Revere gold resource and upgraded its Mt Edon rubidium project in FY2026. Yet the company remains loss-making, has impaired its Mt Dimer development assets and warns that future funding and project cash inflows are needed to support its going-concern assessment.

AdAlta says a 10-year, up to US$120 million agreement between manufacturing partner Oribiotech and an undisclosed commercial-stage biopharmaceutical company validates its choice of IRO automation for future cellular immunotherapies. The deal does not create direct revenue for AdAlta, and its lead asset EW-001 will continue with a separate manufacturing process.